Global drug giant Pfizer has come under attack in the Canadian daily newspaper the National Post for offering C$275.00 ($239.94) to general practitioners and cardio-logists, in return for their participation in a marketing exercise that is alleged to be "highly unethical."
Doctors are said to have been induced to prescribe a drug for cardiac treatment. The pharmaceutical firm says that the survey does not breach ethical guidelines. Concerns about Canadian doctors being influenced to prescribe a drug against their better judgement because 120 GPs and cardiologists had been reimbursed for their time in taking part in a survey, were unfounded, according to Pfizer.
Colin Rose, a cardiologist based at the Montreal, Canada-based McGill University has promised to hand over his fee to the university where he works, and complained to Canada's pharmaceutical industry trade body, the Research-Based Pharmaceutical Companies (Rx&D).
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze